Carl Zeiss Meditec AG (CZMWY)
103.78
-1.43
(-1.36%)
USD |
OTCM |
May 17, 16:00
Carl Zeiss Meditec Net Income (Quarterly): 50.48M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 50.48M |
| December 31, 2023 | 40.28M |
| September 30, 2023 | 92.76M |
| June 30, 2023 | 100.48M |
| March 31, 2023 | 66.59M |
| December 31, 2022 | 52.15M |
| September 30, 2022 | 103.47M |
| June 30, 2022 | 66.61M |
| March 31, 2022 | 101.81M |
| December 31, 2021 | 43.35M |
| September 30, 2021 | 63.76M |
| June 30, 2021 | 98.33M |
| March 31, 2021 | 65.44M |
| December 31, 2020 | 55.20M |
| September 30, 2020 | 62.19M |
| June 30, 2020 | 5.826M |
| March 31, 2020 | 27.69M |
| December 31, 2019 | 42.96M |
| September 30, 2019 | 56.55M |
| June 30, 2019 | 57.09M |
| March 31, 2019 | 33.39M |
| December 31, 2018 | 32.75M |
| September 30, 2018 | 51.82M |
| June 30, 2018 | 30.89M |
| March 31, 2018 | 33.87M |
| Date | Value |
|---|---|
| December 31, 2017 | 33.56M |
| September 30, 2017 | 49.31M |
| June 30, 2017 | 33.85M |
| March 31, 2017 | 32.90M |
| December 31, 2016 | 33.34M |
| September 30, 2016 | 34.08M |
| June 30, 2016 | 22.35M |
| March 31, 2016 | 34.50M |
| December 31, 2015 | 18.27M |
| September 30, 2015 | 11.11M |
| June 30, 2015 | 24.57M |
| March 31, 2015 | 13.24M |
| December 31, 2014 | 22.89M |
| September 30, 2014 | 23.18M |
| June 30, 2014 | 24.67M |
| March 31, 2014 | 26.54M |
| December 31, 2013 | 27.36M |
| September 30, 2013 | 34.05M |
| June 30, 2013 | 31.35M |
| March 31, 2013 | 25.24M |
| December 31, 2012 | 30.26M |
| September 30, 2012 | 23.84M |
| June 30, 2012 | 17.34M |
| March 31, 2012 | 29.35M |
| December 31, 2011 | 22.78M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
5.826M
Minimum
Jun 2020
103.47M
Maximum
Sep 2022
62.65M
Average
59.64M
Median
Net Income (Quarterly) Benchmarks
| Affimed NV | -21.76M |
| InflaRx NV | -10.49M |
| MorphoSys AG | 51.98M |
| BioNTech SE | -342.26M |
| Immatics NV | -3.317M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 512.82M |
| Total Expenses (Quarterly) | 442.53M |
| EPS Diluted (Quarterly) | 0.5648 |
| Enterprise Value | 9.260B |
| Gross Profit Margin (Quarterly) | 53.49% |
| Profit Margin (Quarterly) | 9.84% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 3.67% |
| Normalized Earnings Yield | 3.069 |